MASS 908 Devices Inc.

QT69

NASDAQ·Healthcare·Medical - Specialties·USA

Latest market price

11.25

-1.60-12.45%

Overview Short InterestFilings

MASSQT69908 Devices Inc.·NASDAQ

Overview Short InterestFilings

11.25-12.45%

News

Down 12.5% — Riverwater Micro Opportunities Strategy Q3 2026 Portfolio Activity (seekingalpha.com).

Medium confidence

Loading chart...

Signal & projected range

Gap down — mean-reversionHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

BWAY-4.78%$11.36 SI-6.41%$19.13 MOBI-6.12%$10.58 MLAB-3.92%$127.81 LAB-1.61%$0.61 QDEL-3.71%$13.25 STE-2.16%$227.12 ALC+0.45%$71.45

Snapshot

Index	—	P/E	—	EPS (ttm)	-0.95	Insider Own	20.17%	Shs Outstand	41.33M	Perf Week	-2.09%

Market Cap	465.00M	Forward P/E	—	EPS next Y	-0.46	Insider Trans	-11.66%	Shs Float	32.69M	Perf Month	-10.07%

Enterprise Value	367.00M	PEG	—	EPS next Q	-0.16			Short Float	8.28%	Perf Quarter	33.61%

Income	-35.00M	P/S	7.75	EPS this Y	—			Short Ratio	6.48	Perf Half Y	65.20%

Sales	60.00M	P/B	3.66	EPS next Y	—	ROA	-17.46%	Short Interest	2.71M	Perf YTD	114.29%

Book/sh	3.07	P/C	4.56	EPS next 5Y	—	ROE	-25.50%	52W High	13.35 -15.73%	Perf Year	46.29%

Cash/sh	2.47	P/FCF	—	EPS past 3/5Y	—	ROIC	-18.70%	52W Low	5.03 123.66%	Perf 3Y	107.18%

Dividend Est.	—	EV/EBITDA	—	Sales past 3/5Y	6.01% 15.71%	Gross Margin	49.79%	Volatility	6.55% 5.28%	Perf 5Y	-67.59%

Dividend TTM	—	EV/Sales	6.12	EPS Y/Y TTM	—	Oper. Margin	-46.01%	ATR (14)	0.69	Perf 10Y	—

Dividend Ex-Date	—	Quick Ratio	2.38	Sales Y/Y TTM	1.69%	Profit Margin	-56.68%	RSI (14)	45.77	Recom	2.00

Dividend Gr. 3/5Y	—	Current Ratio	2.67	EPS Q/Q	11.11%	SMA20	-5.45%	Beta	0.63	Target Price	12.00

Payout	0.00%	Debt/Eq	0.03	Sales Q/Q	23.08%	SMA50	0.27%	Rel Volume	1.29	Prev Close	12.85

Employees	172	LT Debt/Eq	0.03	Earnings	Nov 10	SMA200	34.46%	Avg Volume	425.73K	Price	11.25

IPO Date	Dec 18, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-125.35% 4.55%	Net Debt/EBITDA	—	Volume	550,981	Change	-12.45%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Aug-12-26	Reiterated	Stifel Nicolaus		$12
Aug-05-25	Upgrade	Leerink Partners	Market Perform → Outperform
Nov-13-24	Downgrade	Leerink Partners	Outperform → Market Perform

Latest News· Times ET

Oct-30-26

Oct-30-2605:55AM

Riverwater Micro Opportunities Strategy Q3 2026 Portfolio Activityseekingalpha.com

Oct-29-26

Oct-29-2609:30AM

Integer (ITGR) Q3 Earnings and Revenues Miss EstimatesYahoo

Oct-27-26

Oct-27-2607:00AM

908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026businesswire.com

Oct-13-26

Oct-13-2603:29AM

Critical Contrast: TTM Technologies (NASDAQ:TTMI) versus 908 Devices (NASDAQ:MASS)defenseworld.net

Oct-06-26

Oct-06-2611:01AM

908 Devices (NASDAQ:MASS) Hits New 52-Week High – Here’s What Happeneddefenseworld.net

Sep-29-26

Sep-29-2610:15AM

Masivo Silver Reports Broad Polymetallic Mineralization from Initial 2026 Drilling Program at Cerro Colorado Project, Sonora, Mexiconewsfilecorp.com

Sep-21-26

Sep-21-2606:29AM

Financial Analysis: IPG Photonics (NASDAQ:IPGP) vs. 908 Devices (NASDAQ:MASS)defenseworld.net

Sep-20-26

Sep-20-2605:54AM

908 Devices (NASDAQ:MASS) SVP Sells $53,726.54 in Stockdefenseworld.net

05:09AM

Insider Selling: 908 Devices (NASDAQ:MASS) SVP Sells $216,343.89 in Stockdefenseworld.net

Sep-18-26

Sep-18-2612:25AM

Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving PremarketBenzinga

Sep-12-26

Sep-12-2603:49AM

Comparing 908 Devices (NASDAQ:MASS) & Plexus (NASDAQ:PLXS)defenseworld.net

Sep-10-26

Sep-10-2604:09AM

Canaccord Genuity Initiates Coverage On 908 Devices with Buy Rating, Announces Price Target of $13.5Benzinga

Sep-04-26

Sep-04-2603:29AM

BlackRock Inc. Takes $16.91 Million Position in 908 Devices Inc. $MASSdefenseworld.net

Sep-01-26

Sep-01-2607:00AM

908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposiumbusinesswire.com

Aug-30-26

Aug-30-2603:05PM

908 Devices Inc. (MASS) Presents at 17th Annual Midwest IDEAS Conference - SlideshowSeekingAlpha

Company

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	60	56	60	50	—	—	—	—	—
Cost of Goods Sold Incl. D&A	31	29	30	25	—	—	—	—	—
Gross Profit	30	27	30	25	—	—	—	—	—
Selling, General and Administrative Excl. Other	39	37	0	0	—	—	—	—	—
Research and Development	13	14	25	22	—	—	—	—	—
Other Operating Expense	6	0	82	46	—	—	—	—	—
Operating Income	-29	-24	-77	-43	—	—	—	—	—
Interest Expense	0	0	0	0	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-6	-9	4	6	—	—	—	—	—
Net Income Before Taxes	-35	-33	-72	-37	—	—	—	—	—
Income Taxes	0	0	0	0	—	—	—	—	—
Consolidated Net Income	-35	-37	-72	-36	—	—	—	—	—
Net Income From Continuing Operations	-35	-33	-72	-36	—	—	—	—	—
Net Income	-35	-37	-72	-36	—	—	—	—	—
EPS (Recurring)	-0.93	-1.01	-2.12	-1.13	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.93	-1.01	-2.12	-1.13	—	—	—	—	—
EPS (Diluted)	-0.95	-0.94	-2.12	-1.13	—	—	—	—	—
EBITDA	-31	-29	-44	-40	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	7.13	3.38	1.25	7.18	—	—	—	—	—
Gross Margin	50.00	48.21	50.00	50.00	—	—	—	—	—
Operating Margin	-48.33	-42.86	-128.33	-86.00	—	—	—	—	—
Net Margin	-58.33	-66.07	-120.00	-72.00	—	—	—	—	—
Shares Outstanding	38	36	34	32	—	—	—	—	—
Market Capitalization	428	189	75	359	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brown Christopher D.	Director	Oct 07 '26	Sale	11.89	30,000	356,700	745,559	Oct 09
Brown Christopher D.	Director	Oct 07 '26	Option Exercise	1.75	60,000	105,000	805,559	Oct 09
Griffith Joseph H. IV	Chief Financial Officer	Oct 06 '26	Sale	13.03	5,000	65,150	116,497	Oct 08
AWM Investment Company, Inc.	10% Owner	Sep 29 '26	Sale	11.52	18,000	207,322	4,736,773	Oct 01
AWM Investment Company, Inc.	10% Owner	Sep 24 '26	Sale	11.36	24,000	272,626	4,754,773	Sep 25
AWM Investment Company, Inc.	10% Owner	Sep 23 '26	Sale	11.25	1,000	11,250	4,755,773	Sep 25
Kenneweg John	SVP, Sales & Product Marketing	Sep 17 '26	Option Exercise	0.96	5,257	5,047	63,041	Sep 17
Kenneweg John	SVP, Sales & Product Marketing	Sep 17 '26	Sale	10.22	5,257	53,727	57,784	Sep 17
Kenneweg John	SVP, Sales & Product Marketing	Sep 16 '26	Sale	10.11	21,399	216,344	57,784	Sep 17
Kenneweg John	SVP, Sales & Product Marketing	Sep 16 '26	Option Exercise	0.96	21,399	20,543	79,183	Sep 17
Kenneweg John	SVP, Sales & Product Marketing	Sep 15 '26	Sale	10.00	1,000	10,000	57,784	Sep 17
Kenneweg John	SVP, Sales & Product Marketing	Sep 15 '26	Option Exercise	0.96	1,000	960	58,784	Sep 17
Brown Christopher D.	Director	Sep 02 '26	Sale	10.58	30,000	317,400	775,559	Sep 04
Griffith Joseph H. IV	Chief Financial Officer	Aug 25 '26	Sale	10.95	11,459	125,476	121,497	Aug 27
AWM Investment Company, Inc.	10% Owner	Aug 21 '26	Sale	10.61	41,578	441,159	4,779,773	Aug 24

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.